Previous Article | Next Article ![]()
Infect Immun, May 1998, p. 1953-1961, Vol. 66, No. 5
Evans Memorial Department of Clinical
Research and the Department of Medicine, Section of Infectious
Diseases, Boston Medical Center, Boston, Massachusetts
02118,1 and
Center for Cancer Research,
Massachusetts Institute of Technology, Cambridge, Massachusetts
021392
Received 19 June 1997/Returned for modification 5 August
1997/Accepted 25 February 1998
Catalase plays a key role as an antioxidant, protecting aerobic
organisms from the toxic effects of hydrogen peroxide, and in some
cases has been postulated to be a virulence factor. To help elucidate
the function of catalase in Candida albicans, a single
C. albicans-derived catalase gene, designated
CAT1, was isolated and cloned. Degenerate PCR primers based
on highly conserved areas of other fungal catalase genes were used to
amplify a 411-bp product from genomic DNA of C. albicans
ATCC 10261. By using this product as a probe, catalase clones were
isolated from genomic libraries of C. albicans. Nucleotide
sequence analysis revealed an open reading frame encoding a protein of
487 amino acid residues. Construction of a CAT1-deficient
mutant was achieved by using the Ura-blaster technique for sequential
disruption of multiple alleles by integrative transformation using
URA3 as a selectable marker. Resulting mutants exhibited
normal morphology and comparable growth rates of both yeast and
mycelial forms. Enzymatic analysis revealed an abundance of catalase in
the wild-type strain but decreasing catalase activity in heterozygous
mutants and no detectable catalase in a homozygous null mutant. In
vitro assays showed the mutant strains to be more sensitive to damage
by both neutrophils and concentrations of exogenous peroxide that were
sublethal for the parental strain. Compared to the parental strain, the
homozygous null mutant strain was far less virulent for mice in an
intravenous infection model of disseminated candidiasis. Definitive
linkage of CAT1 with virulence would require restoration of
activity by reintroduction of the gene into mutants. However, initial
results in mice, taken together with the enhanced susceptibility of
catalase-deficient hyphae to damage by human neutrophils, suggest that
catalase may enhance the pathogenicity of C. albicans.
Candida albicans, an
opportunistic pathogenic fungus, is the predominant etiologic agent of
mycoses in immunocompromised hosts (2, 29, 41). The fact
that the organism is diploid and has no known sexual cycle has hindered
the genetic study of potential virulence factors of this increasingly
common cause of serious infections. Recent advances in molecular
genetic techniques have considerably enhanced the ability to identify
and analyze factors that may contribute to the pathogenicity of
C. albicans (11, 13). Many cellular properties
have been postulated to contribute to the virulence of C. albicans. However, it has been possible to relate only a few
factors directly to decreased virulence in vivo by using disruption of
specific genes or isolation of variants deficient in particular
enzymes. Such putative pathogenicity factors include secreted aspartyl
proteinases (20, 24, 34), topoisomerase I (16),
1,3- Since the host immune response also plays a key role in the ability of
C. albicans to cause infection, many studies have focused on
the mechanisms involved in the killing of this organism. Neutropenia has been shown to be a major factor contributing to susceptibility to
disseminated candidiasis in humans. Our own data (6-8) and those of others (22, 39) emphasize the primary importance of
oxidative fungicidal mechanisms by human neutrophils
(polymorphonuclear leukocytes [PMNs]) and monocytes. These
mechanisms depend largely on the ability of PMNs to synthesize potent
oxidants primarily derived from hydrogen peroxide, including
H2O2 itself, as well as hydroxyl radical,
hypochlorous acid, and chloramines (6-8). This crucial role
of oxidant-mediated fungicidal effects dictates a need to define fungal
antioxidant defenses. Because exogenous antioxidants, including
catalase, impair killing of C. albicans hyphae by PMNs
(6, 7, 44) and production of H2O2 by
PMNs correlates directly with fungicidal activity (9),
catalase is presumed to be an important antioxidant defense in C. albicans. Therefore, we investigated the role of catalase in
resistance of the fungus to leukocyte-mediated killing. Since
H2O2 is highly diffusible across cell walls,
catalases provide essential intracellular antioxidant activity for many
organisms, including Saccharomyces cerevisiae and other
fungi (4, 15, 17, 42). Catalases are also known to
contribute to growth regulation and development in many eukaryotic
organisms (17, 26, 28, 43). To study the significance of
catalase in the pathogenicity of C. albicans, a single gene
was cloned and subsequently disrupted, producing a homozygous mutant
that was morphologically identical to the parental wild-type strain
and that grew at a comparable rate. Deletion of the catalase gene
was associated with increased susceptibility to leukocyte-mediated
killing of organisms and to decreased virulence for mice in an
experimental model of disseminated candidiasis.
(This work was presented in part at the ASM Conference on
Candida and Candidiasis: Biology, Pathogenesis, and
Management, San Diego, Calif., 24-27 March 1996.)
Strains, media, and culture conditions.
The C. albicans strains used in this study were ATCC 10261, CAI4, 1006, 4918, and SC5314. Strains ATCC 10261, 1006, 4918, and SC5314 are
clinical isolates. CAI4 is a homozygous ura3 strain isogenic
to the clinical isolate SC5314 and was originally obtained from W. Fonzi (11). All strains were routinely propagated in YEPD
(2% Bacto Peptone [Difco Laboratories, Detroit, Mich.], 1% yeast
extract, 2% glucose), Sabouraud-dextrose, or SD (0.7% yeast nitrogen
base, 2% glucose) medium at 30°C. Agar was added (2%) for solid
media. Yeast cells were induced to form germ tubes in either RPMI 1640 or synthetic amino acid-rich medium (21) at 37°C. Media
were supplemented with 50 µg of uridine ml Gene cloning.
Degenerate primers were used in a PCR to
amplify a CAT1 gene fragment from C. albicans
genomic DNA, which was subcloned into pBluescript SK(+) (Stratagene, La
Jolla, Calif.), creating plasmid pCAT01. This PCR fragment was verified
as the CAT1 gene by sequence analysis and used to probe
C. albicans genomic DNA after digestion with restriction
enzymes. Genomic clones were obtained from libraries constructed from
genomic DNA of strains 1006 and 4918. The libraries were originally
obtained from D. Miller and X. J. Zhao, respectively. Briefly, a
C. albicans genomic library was prepared from strain 1006 on
a URA3 2µm vector. Strain 4918 was used to construct a XhoI genomic library in DNA sequencing.
Sequencing of both DNA strands was carried
out by applying the chain termination method of Sanger et al.
(36) with the SequiTherm cycle sequencing kit (Epicentre
Technologies, Madison, Wis.) and internal labeling with
[ Catalase gene disruption.
A 2,036-bp VspI
fragment containing the entire C. albicans CAT1 gene was
blunted with Klenow fragment of DNA polymerase I and nucleoside
triphosphates and then subcloned into the EcoRV site of
pBluescript SK(+) to create plasmid pCAT10. A 1,351-bp BglII-EcoRV fragment was removed from the open
reading frame (ORF) of CAT1, followed by addition of
BglII linkers and ligation of a
BamHI-BglII fragment of plasmid p5921 (1,
14) which contained the C. albicans URA3 gene flanked
by direct repeats of the 1.1-kb Salmonella typhimurium hisG
gene. The resulting plasmid, designated pCAT20, was fragmented by
digestion with restriction endonucleases and used to transform strain
CAI4 by a lithium acetate method (12). Selection of
Ura3 Southern and Northern blot analyses.
Standard
electrophoretic techniques and formaldehyde RNA gels were employed
(35, 37). DNA fragments used as hybridization probes were
isolated from agarose gels by using a gel extraction kit (QIAGEN Inc.,
Santa Clarita, Calif.) and labeled with [ Chromosomal location of CAT1.
Chromosomal DNA was
resolved by pulsed-field gel electrophoresis with a contour-clamped
homogeneous electric field system and transferred to a nylon membrane
(46). The chromosomal blot was kindly provided by J. Sturtevant at Georgetown University Medical Center. A 1,156-bp
EcoRI fragment of C. albicans CAT1 was labeled
with [ Fungal growth rates.
The growth rates of the parental and
mutant strains at 25 and 37°C were compared. To measure yeast-phase
growth, both strains were incubated at 25°C with shaking, in YEPD,
Lee's (21), or RPMI 1640 medium. Absorbance at 650 nm was
measured after 4 and 8 h and then every 2 h up to 24 h.
The ability of yeasts to form hyphae was analyzed by induction of
mycelia at 37°C in RPMI 1640 medium. After 2, 3, and 4 h of
incubation, organisms were examined microscopically to determine both
the relative size of hyphae and the percentage of organisms exhibiting
formation of germ tubes.
Hydrogen peroxide sensitivity.
C. albicans hyphae
(3 × 106 ml Enzymatic assay of catalase activity.
A standard enzymatic
assay (42) was used to measure catalase levels of C. albicans parental and mutant strains. Germinated organisms from
each strain were disrupted by vortexing with glass beads in 100 mM
potassium phosphate buffer followed by centrifugation to obtain cell
extracts of the organisms. Catalase activity was measured by the rate
of decomposition of H2O2 as measured
spectrophotometrically at 240 nm. Enzymatic activity was standardized
for protein content.
Assay of fungal damage by PMNs.
PMNs were purified from
normal human whole blood by dextran sedimentation followed by
Hypaque-Ficoll centrifugation and hypotonic lysis of contaminating
erythrocytes (9). C. albicans yeasts were induced
to form hyphae by incubation in RPMI 1640 medium, with shaking for
3 h at 37°C. PMNs and serum-opsonized hyphae were incubated
together at various ratios for 60 min at 37°C. The reaction of PMNs
and hyphae was stopped by the addition of ice-cold H2O
followed by centrifugation to ensure lysis of PMNs. Survival of hyphae
was measured by reduction of the tetrazolium dye XTT, as described
above.
Experimental infections in mice.
Male outbred ICR mice, 4 to
5 weeks old (Harlan-Sprague-Dawley, Indianapolis, Ind.), were housed 7 to 10 per cage. Food and water were given ad libitum, according to
National Institutes of Health guidelines. Strains of C. albicans were grown in Sabouraud-dextrose broth at 26°C to a
cell density of 107 conidia ml Statistical analyses.
The Wilcoxon rank sum test was used to
compare survival rates of control and mutant groups of mice. In vivo
groups consisted of 7 to 10 animals per inoculum, and virulence studies
were performed twice. In vitro experiments were done in triplicate and
repeated at least three times. Means ± standard deviations were
determined for all data points. Groups were compared by using the
Student t test for paired samples.
Nucleotide sequence accession number.
The GenBank accession
number for the C. albicans catalase gene CAT1 is
U40704.
Cloning of the C. albicans CAT1 gene.
Degenerate
PCR primers were designed based on the highly conserved amino acid
sequences encoded by genes for catalases in other fungi (Fig.
1). These primers amplified a 411-bp
product from genomic DNA of C. albicans ATCC 10261. The PCR
product was used to probe C. albicans genomic DNA of several
strains after digestion with a variety of restriction enzymes. A 1.2-kb
EcoRI fragment was identified in each strain. No other
fragments were observed in these digests. An EcoRI-digested
C. albicans genomic library was screened by colony
hybridization, which resulted in the identification of several positive
clones. After selective purification and subcloning of a 5-kb
PstI fragment into pBluescript SK(+), the nucleotide
sequence of the catalase isolate was determined. Ultimately, since
analyses of several clones revealed identical but partial sequences,
another library was screened for catalase-positive clones. Sequence
analysis of a portion of a 10.5-kb SpeI fragment isolated
from a C. albicans 4918 XhoI genomic library in
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Cloning and Sequencing of a Candida
albicans Catalase Gene and Effects of Disruption of This
Gene
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
-glucosyltransferase (38), and chitin synthase III
(3).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
1 as
required. Selection of auxotrophs was on medium containing 5-fluoroorotic acid (5-FOA) as described previously (11).
DNA cloning was carried out in Escherichia coli DH5
.
FIXII (48). Fragments
isolated from clones were subcloned into pBluescript SK(+) and
subsequently analyzed by sequencing both DNA strands.
-35S]dATP. Synthetic oligonucleotide primers for
sequencing were obtained from either Gibco/BRL (Gaithersburg, Md.) or
the Biopolymer Laboratory at the Massachusetts Institute of Technology.
DNA and amino acid sequences were analyzed by using DNAStar software.
isolates resulting from cis recombination
between the hisG repeats was facilitated by plating
transformants onto medium containing 0.1% (wt/vol) 5-FOA and 50 µg
of uridine ml
1. The disruption transformation was
repeated until a null mutant was generated. Both pre- and post-5-FOA
isolates were verified by Southern blot analyses.
-32P]dCTP
(New England Nuclear, Boston, Mass.) by random oligonucleotide priming
as described in the manufacturer's instructions (Boehringer Mannheim,
Indianapolis, Ind.). Blotting was carried out with Hybond-N nylon
membranes (Amersham, Chicago, Ill.) as described in the manufacturer's
instructions.
-32P]dCTP by the random priming method and used
to probe the chromosomal blot by the same methods of Southern
hybridization as those described above.
1) were exposed to
H2O2 in concentrations ranging from 0.125 to
4.0 mM. After incubation at 37°C for 1 h, fungal damage was
assessed by using the tetrazolium
dye (2,3)-bis-(2-methoxy-4-nitro-5-sulfenyl)-(2-H)-tetrazolium-5-carboxanilide (XTT).
Hyphae were washed to remove any residual H2O2
and then incubated in 400 µl of 0.5 mg of XTT ml
1 with
the addition of 8 µg of coenzyme Q
(2,3-dimethoxy-5-methyl-1,4-benzoquinone) ml
1 for 1 h at 37°C. Prior studies established that XTT was reduced only by
live organisms, yielding a water-soluble formazan product, which is a
sensitive and reproducible indicator of metabolic inactivation (27). Absorbance of supernatants at 450 nm was used to
calculate the percentage of damaged hyphae.
1. Cells were
harvested, washed, and resuspended in sterile H2O. Immunocompetent mice were infected by intravenous inoculation of 0.1 ml
of a suspension of 105 to 109 conidia per ml,
via the lateral tail veins. Cages were checked daily for dead or
moribund mice. Moribund mice were euthanized by CO2
asphyxiation. The lungs, livers, and kidneys were removed from two
euthanized mice from each group on days 1, 5, and 32 postinfection.
Organs were homogenized, diluted, and plated onto Sabouraud-dextrose
agar and incubated for 24 to 48 h at 37°C to determine CFU per
organ. Necropsy was performed on lungs, livers, and kidneys of mice
from each group to detect the presence of C. albicans.
Paraffin sections were prepared from organs preserved in buffered
formalin and stained with Grocott's methenamine silver nitrate and
counterstained with hematoxylin and eosin.
![]()
RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
FIXII confirmed that the complete gene was present. The
SpeI fragment was cloned into pBluescript SK(+) and used for
sequence analysis.

View larger version (96K):
[in a new window]
FIG. 1.
Alignment of the deduced amino acid sequences of the
C. albicans catalase (C. alb.) with the catalases
of C. tropicalis (C. trop.) and S. cerevisiae (Yeast A and Yeast T). Identical residues are boxed.
Dashes indicate gaps in the amino acid sequence when compared to other
sequences. Amino acids in boldface type indicate regions used to design
degenerate primers. Arrows indicate directions of degenerate PCR
primers. Alignment was generated by using MegAlign (DNAStar).
Nucleotide and deduced amino acid sequences of the CAT1
gene.
The nucleotide sequence of the entire catalase gene and
flanking sequences both upstream and downstream of the start codon were
determined on both strands of a full-length clone by using a series of
synthetic oligonucleotides. The DNA sequence containing the putative
C. albicans CAT1 homolog contained a single ORF of 1,461 bp
with the potential to encode a protein of 487 amino acids, without
introns. The first ATG of the ORF is located 12 bases downstream from a
putative TATA box, while one in-frame TAA stop codon was observed 24 bases upstream from the proposed start codon. Analysis of the sequence
also revealed the presence of a purine nucleotide (A) located at
position
3 and another (G) at position +4 (19). These have
been identified as important for recognition by eukaryotic ribosomes
(19). A TAA translation termination codon was located 13 bases upstream from a possible yeast transcriptional stop signal
(47), followed by a putative polyadenylation signal at the
3' end of the nucleotide sequence. The protein displayed 92.4, 63.2, and 39.6% identities to the amino acid sequences of the catalase of
Candida tropicalis, S. cerevisiae catalase A, and
S. cerevisiae catalase T, respectively (Fig. 1).
Southern analysis of disrupted alleles of C. albicans
CAT1.
To disrupt the CAT1 alleles, a 1,351-bp
BglII/EcoRV fragment of the ORF was replaced by
the Ura-blaster cassette (Fig. 2A), a
4-kb BamHI/BglII fragment of p5921 that consists
of a functional C. albicans URA3 gene flanked by direct
repeats of the Salmonella typhimurium hisG (14).
The resulting plasmid was digested with KpnI and
SacI and used to transform CAI4, a homozygous
ura3 strain isogenic to the clinical isolate SC5314. The
repeats of hisG promote homologous cis
recombination, resulting in the excision of URA3 and the
loss of one copy of hisG, leading to regeneration of
Ura3
auxotrophs (14). Several independent
Ura3
transformants were selected by resistance to 5-FOA
and analyzed by Southern hybridization to verify the loss of one copy
of the wild-type CAT1 gene. Analysis revealed that 67% of
these primary transformants were heterozygous mutants (designated
CADW1). Six of these heterozygous mutants were subjected to a second
round of transformation using URA3 as a selectable marker.
Southern analysis of 36 secondary transformants after 5-FOA selection
resulted in eight mutants that contained only wild-type
CAT1, suggesting the possibility that gene conversion with a
wild-type allele had led to regeneration of the parental pattern or
that there were contaminating wild-type organisms in some of the
transformations. The remaining 28 transformants were heterozygous,
showing evidence of both wild-type and disrupted CAT1
alleles. Six of these heterozygous mutants (designated CADW2) were
subjected to a third round of transformation that yielded 50%
homozygous mutants containing no wild-type CAT1 and 50%
that still exhibited both wild-type and disrupted alleles after
Southern analysis. Homozygous null mutants obtained were designated
CADW3. The patterns observed in the autoradiogram of the Southern blot
(Fig. 2B) suggested that complete elimination of CAT1 from
the wild-type strain required three successive disruptions. After one
round of transformation and subsequent 5-FOA selection, lane 3 showed a
heterozygous mutant with at least one wild-type allele and one
disrupted allele containing a copy of hisG. Lane 5 also
showed a heterozygous mutant, obtained after the second round of
transformation and 5-FOA selection. Bands on the autoradiogram
indicated the presence of a wild-type allele and at least one copy of
the disrupted CAT1 allele containing a single copy of
hisG. As shown in lanes 6 and 7 of Fig. 2B, no bands were
observed at the original location of the wild-type allele. The presence
of hisG in each of the disrupted alleles in lanes 3 to 7 (cat1::hisG) was confirmed by hybridization with a
hisG probe (data not shown). As expected, the
hisG probe also hybridized with
cat1::hisG/URA3/hisG bands (lanes 2, 4, and 6) but
not with any of the CAT1 bands (lanes 1 to 5). The
homozygous null mutant was produced only after three successive rounds
of transformation. In addition, four other independent primary
transformants that were selected by 5-FOA resistance were found to
produce the same patterns on Southern blots with each successive
transformation, until formation of null mutants.
|
Northern analysis of C. albicans CAT1 expression. Expression levels of CAT1 were compared for the heterozygous and homozygous mutants by preparing total RNA from wild-type and each mutant strain followed by Northern hybridization and autoradiography. There was a progressive decrease in expression of CAT1 after each transformation (Fig. 3). The size of the transcript was approximately 1.8 kb, based on ethidium bromide-stained standards. The expression of CAT1 in the yeast phase of the wild-type strain was also compared to expression in the mycelial or hyphal phase. Preliminary data from this experiment indicated that both yeast and hyphae expressed the message and suggested a slight relative increase in the expression of CAT1 in the yeast phase of growth (data not shown).
|
Chromosomal location of C. albicans CAT1. Separations of C. albicans 4918, ATCC 10261, and CAI4 by a contour-clamped homogeneous electric field system were probed under conditions of high stringency with a 1.2-kb EcoRI fragment of C. albicans CAT1, which hybridized to chromosome 1 in all three strains (Fig. 4).
|
Phenotypic analysis of the CAT1 disruptant. There were no significant differences in growth rates of the wild-type parental strain, SC5314, and the homozygous CAT1 mutant, strain CADW3. Rates of yeast-phase growth were compared by incubating both strains at 25°C and measuring absorbance at 650 nm (Fig. 5A). Hyphal germination and rates of extension formation were also compared. Both strains were induced to form germ tubes in RPMI 1640 medium at 37°C. Comparisons of percentages germinated (Fig. 5B) and lengths of hyphae (data not shown) revealed no differences between the strains after 2, 3, and 4 h of incubation. Microscopic examination of the strains revealed no evident morphological differences between SC5314 and CADW3. Conversely, compared to the parental SC5314 strain, the catalase-deficient mutant strain, CADW3, had a decreased survival rate upon exposure to various concentrations of hydrogen peroxide (Fig. 5C).
|
Quantitation of catalase by enzymatic assay. Catalase activity from each strain was determined by H2O2 decomposition. Each successive disruption of a CAT1 allele was associated with a progressive decrease in catalase enzymatic activity per milligram of protein in hyphal cell extracts from each strain. Relative activities of catalase in hyphae from the heterozygous mutants lacking one or two alleles of wild-type catalase (strains CADW1 and CADW2, respectively) were reduced significantly to 62.6% ± 13.7% and 37.2% ± 5.0%, respectively, of catalase activity in the parental strain (P < 0.001 by the Student t test for paired samples). No catalase activity was detected in the homozygous null mutant (CADW3).
In vitro assay of neutrophil damage. C. albicans hyphae from both the parental strain and the catalase-deficient homozygous mutant strain were damaged during incubations with neutrophils, as indicated by a reduced ability to metabolize the tetrazolium dye XTT. When hyphae were mixed for 1 h with neutrophils at PMN:hypha ratios ranging from 0.5:1 to 10:1, the metabolic activity of catalase-deficient organisms was significantly lower than that of the parental strain (Fig. 6). In experiments done at a PMN:hypha ratio of 25:1, the metabolic activities of both the heterozygous and homozygous mutants also were significantly less than that of the parental strain (data not shown), although the differences were not as striking as those seen at the lower PMN:hypha ratios.
|
Experimental infections in mice.
To test the effect of the
CAT1 deletion on virulence in an animal model, strains
SC5314 and CADW3 (
cat1) were used to infect immunocompetent mice. Since it has been shown that virulence is decreased by the ura3 mutation (18, 25, 32, 40),
only the Ura+ strain of the homozygous null mutant,
isolated prior to treatment with 5-FOA, was used to infect mice. For
each inoculum of organisms tested, mice infected with the
catalase-deficient CADW3 strain survived significantly longer than did
mice infected with the wild-type SC5314 parental strain
(P < 0.001 by Wilcoxon rank sum test for all inocula
in each of two separate experiments). In vivo experiments were
performed twice with similar results. Data from both experiments are
shown in Fig. 7. In experiment 2, an inoculum of 107 CFU of the wild-type strain produced lethal
infections in 100% of the mice within 13 days, while 40% of mice
infected with an equal inoculum of the CAT1 mutant remained
alive at day 30. With a smaller inoculum of 105 CFU, all
mice infected with the wild-type strain died within 22 days, compared
with an 80% survival rate (at day 30) of mice inoculated with the
mutant strain (experiment 2). Quantitative cultures of lungs, livers,
and kidneys from two euthanized mice in each group at each time point
(Fig. 8) revealed that clearance of
C. albicans from the lungs and the liver was achieved by day 5 postinoculation in mice infected with the catalase-deficient CADW3
strain. In contrast, live organisms persisted for the entire 32-day
duration of the experiment in mice infected with sublethal doses of
SC5314 (Fig. 8A).
|
|
auxotrophic mutants might have occurred. Groups of
mice were challenged with 105 C. albicans
organisms from either the parental strain (SC5314), the CADW1 strain
(with a single deletion of CAT1), the CADW2 strain (with a
double deletion of CAT1), or the CADW3 strain (with a triple
CAT1 deletion;
cat1). Mice infected with
strain CADW1, the likeliest spontaneous revertant, had a median
survival after infection of 8.5 days, not significantly different from
the survival after infection with parental strain SC5314 (6 days,
P = 0.156 by Wilcoxon rank sum test). By comparison,
median survival times were 12 days with the double deletion
CAT1 (CADW2) strain and 13 days with the triple deletion
mutant strain (CADW3;
cat1) in this experiment. Mice
infected with strain CADW1 also had significantly more organisms in
kidneys cultured 5 days after infection than did mice infected with
either strain CADW2 or strain CADW3. These data further supported the
relationship between reduced virulence and the loss of CAT1.
Differences in virulence between the homozygous null mutant and a
heterozygous mutant strain with URA3 at the same site also
made it unlikely that instability of the URA3 marker caused
attenuation of virulence.
| |
DISCUSSION |
|---|
|
|
|---|
These experiments describe the first isolation and derived sequence of the C. albicans CAT1 gene by use of a PCR probe constructed on the basis of homologous sequences of other fungal catalases. The predicted amino acid sequence encoded by the gene showed a high level of identity to the sequences of catalases from other fungi, suggesting that catalases are highly conserved.
Sequential disruptions of three apparent copies of the gene were required for total elimination of expression and enzymatic activity of catalase. Since C. albicans has been shown to be a diploid organism by others (31, 33), it seems possible that an additional copy of the gene may have been introduced during early transformation. Alternatively, the parental strain may have had a duplication of part or all of chromosome 1, on which the catalase gene was localized. Others have also reported requiring three successive disruptions to eliminate activity of a chitin synthase in C. albicans SGY243 (14). Our data did indicate that each successive disruption of a catalase allele resulted in an incremental decrease in catalase enzymatic activity. Both enzymatic assays of catalase activity and Northern blot analyses of the two heterozygous and the homozygous mutants revealed a progressive decrease in expression of CAT1.
Our data showed that deletion of CAT1 did not alter the phenotype or morphology of the strain but did dramatically attenuate the ability of the organism to resist damage by human leukocytes in vitro. In addition, organisms that totally lacked catalase activity had a significantly reduced capacity to cause progressive infection in vivo. These differences could not be explained by altered growth or germination of catalase-deficient mutants. In multiple in vitro assays measuring both yeast-phase growth and extent and time required for germination, there were no discernible differences in growth rate or hyphal development between the parental strain with normal catalase activity and the completely catalase-deficient mutant strain. Thus, CAT1 did not appear to be an essential gene for growth or germination.
Catalase-deficient mutant organisms also retained the ability to survive in vivo after infection of mice, although they were ultimately cleared from tissues of surviving animals. Combined with the increased susceptibility of catalase-deficient organisms to injury by neutrophils, the reduced ability of CAT1 disruptants to cause progressive murine disseminated candidiasis suggests that catalase may contribute to the virulence of C. albicans. Our data cannot eliminate the possibility that integration of transforming DNA occurred at an ectopic site, potentially altering the activity of an unrelated virulence factor. However, it seems unlikely that this would have fortuitously yielded an identical band of expected size on Southern blots. Moreover, although many C. albicans mutants have been constructed by other investigators, these mutants have behaved as expected and there are no reports, so far, suggesting that transformation of Candida induced mutations at other sites. While this does not eliminate the concern, it at least suggests that secondary genotypic alterations do not occur frequently. There also remains a possibility that inadvertent introduction of duplicated genes during the transformation process, if it occurred, might conceivably have changed dosages of other genes controlling potential virulence factors. Although direct experimental evidence is necessary to address these and other issues, current published data suggest that secondary genetic alterations do not occur at high frequency. Even so, additional studies will be required to definitively determine the role of catalase as a virulence factor.
Since auxotrophic strains of C. albicans have exhibited greatly attenuated virulence (18, 25, 32, 40), our studies were done with the prototrophic Ura+ isolate of the homozygous null mutant, recovered prior to 5-FOA treatment. The reduced virulence of the homozygous null mutant suggests that the CAT1 gene is expressed during the course of infection and that this mutant strain has a reduced capacity to cause infection. Histological examination of lung, liver, and kidney tissues revealed high levels of wild-type hyphae and yeast but few mutant organisms. Although the CAT1 deletion strain (CADW3) initially survived in mice and was maintained in murine kidneys for at least 5 days, complete clearance of the organism was eventually achieved. Invasion of the kidneys is often associated with late fatalities in immunocompetent mice since C. albicans has been known to persist and grow preferentially in hyperosmolar areas of the kidney during disseminated infections (29). Clearance of the null mutant strain from lung and liver tissue was much faster, with no organisms being detected in these tissues as early as day 5 postinoculation. One of the vagaries of colony counts from infected organs is that organisms may be clumped within infected tissues, leading to falsely low colony counts. This was not the case in these studies of the CAT1-deficient null mutant, as evidenced by the histological examination of organs containing very few organisms, which gave no indication of any clumping.
It has also been suggested that excision of the URA3 gene
might produce spontaneous reversion to auxotrophic Ura
mutants. Were that to occur, any auxotrophs would likely be cleared quickly since Ura
strains cannot scavenge enough uracil
from surrounding tissues to ensure survival. The fact that
catalase-negative organisms caused progressive, ultimately fatal
disseminated candidiasis in some mice indicated that at least some of
these organisms remained Ura+. In addition, survival of
mice challenged with the most likely revertant mutant strain in our
studies, CADW1, with only a single deletion of a
CAT1 allele, was not significantly different from survival
after infection with the parental strain, SC5314.
The relative importance of the catalase gene in the pathogenicity of C. albicans may also depend upon the immune status of the host and the site of infection. The presence of catalase alone does not necessarily have any relevance to the virulence of a fungus since most fungi, including S. cerevisiae, are nonpathogens, causing significant infection in humans only extremely rarely. As with many postulated virulence factors, the CAT1 gene may play a role in the infectious process of C. albicans but seems highly unlikely to be sufficient by itself to account for the ability of the organism to cause disease.
Thus, our data raise the possibility that catalase may be one of several factors that significantly contribute to the virulence of C. albicans. However, definitive evidence will require restoration of the gene and consequent enzymatic activation together with a return of wild-type virulence. The ability to reintroduce such functional, stably active genes has been elusive for many other investigators besides ourselves, but experiments to restore the catalase gene to the mutant strain are in progress. Successful restoration of virulence would address potentially broader effects of catalase gene disruption on gene regulation or additional factors unrelated to deletion of the specific gene itself. However, results of any of these approaches will require extremely cautious interpretations.
Meanwhile, the importance of catalase has already been established in the protection of a variety of organisms against oxidants released by host cells (4, 15, 17) and in its potential ability to regulate growth and development, including phase transition, in some fungi (17, 26, 28, 43). Nevertheless, the present data are not sufficient to establish a definitive role for catalase in the pathogenesis of candidiasis in vivo. However, the clear-cut effects of catalase gene inactivation on sensitivity to neutrophils provide important new evidence supporting the need for further study.
Disseminated candidiasis in nonneutropenic patients continues to be an increasing problem in hospitalized patients (10). Even in neutropenic patients, monocytes and macrophages have been presumed to provide significant, if imperfect, defenses against Candida (23). If future studies show that restoration of catalase activity restores virulence, this may open a potential avenue for combating systemic candidiasis, since even lifelong genetic acatalasemia in humans has not caused severe systemic deleterious effects (30, 45).
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grant AI-15338 (to R.D.D.) from the National Institutes of Health and, in part, by the Collaborative Medical Mycology Research Program (Pfizer, Inc., Roerig Division; Phytera; Scriptgen Pharmaceuticals; and the Section of Infectious Diseases, Boston Medical Center).
We thank Xiuping Liu for invaluable assistance with the animal studies.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Section of Infectious Diseases, Rm. E-336, Boston Medical Center, 88 East Newton St., Boston, MA 02118. Phone: (617) 638-7909. Fax: (617) 638-8070. E-mail: rdiamond{at}med-med1.bu.edu.
Publication 011 from the Collaborative Medical Mycology Research
Program.
Editor: T. R. Kozel
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Alani, E.,
L. Cao, and N. Kleckner.
1987.
A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains.
Genetics
116:541-545 |
| 2. | Beck-Sague, C. M., and W. R. Jarvis. 1993. National nosocomial infections surveillance system. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis. 167:1247-1251[Medline]. |
| 3. |
Bulawa, C. E.,
D. W. Miller,
L. K. Henry, and J. M. Becker.
1995.
Attenuated virulence of chitin-deficient mutants of Candida albicans.
Proc. Natl. Acad. Sci. USA
92:10570-10574 |
| 4. | Cohen, G., W. Rapatz, and H. Ruiz. 1988. Sequence of the Saccharomyces cerevisiae CTA1 gene and amino acid sequence of catalase A derived from it. Eur. J. Biochem. 176:159-163[Medline]. |
| 5. |
Diamond, R. D., and R. A. Clark.
1982.
Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro.
Infect. Immun.
38:487-495 |
| 6. | Diamond, R. D., R. A. Clark, and C. C. Haudenschild. 1980. Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro. J. Clin. Invest. 66:908-917. |
| 7. | Diamond, R. D., and R. Krzesicki. 1978. Mechanisms of attachment of neutrophils to Candida albicans pseudohyphae in the absence of serum, and of subsequent damage to pseudohyphae by microbicidal processes of neutrophils in vitro. J. Clin. Invest. 61:360-369. |
| 8. | Diamond, R. D., R. Krzesicki, and W. Jao. 1978. Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro. J. Clin. Invest. 61:349-359. |
| 9. |
Diamond, R. D.,
C. A. Lyman, and D. R. Wysong.
1991.
Disparate effects of interferon- and tumor necrosis factor- on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro.
J. Clin. Invest.
87:711-720.
|
| 10. | Edwards, J. E. 1991. Invasive Candida infections. Evolution of a fungal pathogen. N. Engl. J. Med. 324:1060-1062[Medline]. (Editorial.) |
| 11. | Fonzi, W. A., and M. Y. Irwin. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728[Abstract]. |
| 12. |
Gietz, D.,
A. St. Jean,
R. A. Woods, and R. H. Schiestl.
1992.
Improved method for high efficiency transformation of intact yeast cells.
Nucleic Acids Res.
20:1425 |
| 13. | Gorman, J. A., W. Chen, and J. W. Gorman. 1991. Repeated use of GAL1 for gene disruption in Candida albicans. Genetics 129:19-24[Abstract]. |
| 14. |
Gow, N. A. R.,
P. W. Robbins,
J. W. Lester,
A. P. J. Brown,
W. A. Fonzi,
T. Chapman, and O. S. Kinsman.
1994.
A hyphal-specific chitin synthase gene (CHS2) is not essential for growth, dimorphism or virulence of Candida albicans.
Proc. Natl. Acad. Sci. USA
91:6216-6220 |
| 15. | Hartig, A., and H. Ruis. 1986. Nucleotide sequence of the Saccharomyces cerevisiae CTT1 gene and the deduced amino-acid sequence of yeast catalase T. Eur. J. Biochem. 160:487-490[Medline]. |
| 16. | Jiang, W., D. Gerhold, E. B. Kmiec, M. Hauser, J. M. Becker, and Y. Koltin. 1997. The topoisomerase I gene from Candida albicans. Microbiology 143:377-386[Abstract]. |
| 17. |
Kawasaki, L.,
D. Wysong,
R. Diamond, and J. Aguirre.
1997.
Two divergent catalase genes are differentially regulated during Aspergillus nidulans development and oxidative stress.
J. Bacteriol.
179:3284-3292 |
| 18. |
Kirsch, D. R., and R. R. Whitney.
1991.
Pathogenicity of Candida albicans auxotrophic mutants in experimental infections.
Infect. Immun.
59:3297-3300 |
| 19. | Kozak, M. 1986. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283-292[Medline]. |
| 20. |
Kwon-Chung, K. J.,
D. Lehman,
C. Good, and P. T. Magee.
1985.
Genetic evidence for role of extracellular proteinase in virulence of Candida albicans.
Infect. Immun.
49:571-575 |
| 21. | Lee, K. L., H. R. Buckley, and C. C. Campbell. 1975. An amino acid liquid synthetic medium for the development of the mycelial and yeast forms of Candida albicans. Sabouraudia 13:148-153[Medline]. |
| 22. |
Lehrer, R. I., and R. G. Jan.
1970.
Interaction of Aspergillus spores with human leukocytes and serum.
Infect. Immun.
1:345-350 |
| 23. | Levitz, S. M. 1992. Overview of host defenses in fungal infections. Clin. Infect. Dis. 14:S37-S42. |
| 24. | Macdonald, F., and F. C. Odds. 1983. Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. J. Gen. Microbiol. 129:431-438[Medline]. |
| 25. | Manning, M., C. B. Snoddy, and R. A. Fromtling. 1984. Comparative pathogenicity of auxotrophic mutants of Candida albicans. Can. J. Microbiol. 30:31-35[Medline]. |
| 26. | Marchler, G., C. Schüller, G. Adam, and H. Ruis. 1993. A Saccharomyces cerevisiae UAS element controlled by a protein kinase A activates transcription in response to a variety of stress conditions. EMBO J. 12:1997-2003[Medline]. |
| 27. | Meshulam, T., S. M. Levitz, L. Christin, and R. D. Diamond. 1995. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2-H)-tetrazolium-5-carboxanilide (XTT). J. Infect. Dis. 172:1153-1156[Medline]. |
| 28. | Navarro, R. E., M. A. Stringer, W. Hansberg, W. E. Timberlake, and J. Aguirre. 1996. CatA, a new Aspergillus nidulans gene encoding a developmentally regulated catalase. Curr. Genet. 29:352-359[Medline]. |
| 29. | Odds, F. C. 1988. In Candida and candidosis: a review and bibliography, 2nd ed. Bailliere Tindall, London, United Kingdom. |
| 30. | Ogata, M. 1991. Acatalasemia. Hum. Genet. 86:331-340[Medline]. |
| 31. |
Olaiya, A. F., and S. J. Sogin.
1979.
Ploidy determination of Candida albicans.
J. Bacteriol.
140:1043-1049 |
| 32. | Polak, A. 1992. Virulence of Candida albicans mutants. Mycoses 35:9-16[Medline]. |
| 33. |
Riggsby, W. S.,
L. J. Torres-Bauza,
J. W. Wills, and T. M. Townes.
1982.
DNA content, kinetic complexity, and the ploidy question in Candida albicans.
Mol. Cell. Biol.
2:853-862 |
| 34. | Ross, I. K., F. DeBernardis, G. W. Emerson, A. Cassone, and P. A. Sullivan. 1990. The secreted aspartate proteinase of Candida albicans: physiology of secretion and virulence of a proteinase-deficient mutant. J. Gen. Microbiol. 136:687-694[Medline]. |
| 35. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. In Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 36. |
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 37. | Saporito, S. M., and P. S. Sypherd. 1991. The isolation and characterization of a calmodulin gene (CMD1) from the dimorphic fungus Candida albicans. Gene 106:43-49[Medline]. |
| 38. |
Sarthy, A. V.,
T. McGonigal,
M. Coen,
D. J. Frost,
J. A. Meulbroek, and R. C. Goldman.
1997.
Phenotype in Candida albicans of a disruption of the BGL2 gene encoding a 1,3- -glucosyltransferase.
Microbiology
143:367-376[Abstract].
|
| 39. | Schaffner, A., H. Douglas, and A. Braude. 1982. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J. Clin. Invest. 69:617-631. |
| 40. |
Shepherd, M. G.
1985.
Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infections.
Infect. Immun.
50:541-544 |
| 41. | Sobel, J. D., and J. Vazquez. 1990. Candidemia and systemic candidiasis. Semin. Respir. Infect. 5:123-137[Medline]. |
| 42. | Ueda, M., S. Mozaffar, and A. Tanaka. 1990. Catalase from Candida boidinii 2201. Methods Enzymol. 188:463-467[Medline]. |
| 43. | Veenhuis, M., M. Mateblowski, W. H. Kunau, and W. Harder. 1987. Proliferation of microbodies in Saccharomyces cerevisiae. Yeast 3:77-84[Medline]. |
| 44. |
Wagner, D. K.,
C. Collins-Lech, and P. G. Sohnle.
1986.
Inhibition of neutrophil killing of Candida albicans pseudohyphae by substances which quench hypochlorous acid and chloramines.
Infect. Immun.
51:731-735 |
| 45. | Wen, J. K., T. Osumi, T. Hashimoto, and M. Ogata. 1990. Molecular analysis of human acatalasemia. Identification of a splicing mutation. J. Mol. Biol. 211:383-393[Medline]. |
| 46. |
Wickes, B. L.,
J. E. Golin, and K. J. Kwon-Chung.
1991.
Chromosomal rearrangement in Candida stellatoidea results in a positive effect on phenotype.
Infect. Immun.
59:2480-2484 |
| 47. | Zaret, K. S., and F. Sherman. 1982. DNA sequence required for efficient transcription termination in yeast. Cell 28:563-573[Medline]. |
| 48. | Zhao, X.-J., and R. L. Cihlar. 1994. Isolation and sequence of the Candida albicans FAS1 gene. Gene 147:119-124[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||